Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Luiza Dib Batista Bugiato Faria"'
Autor:
Rodrigo Ramella Munhoz, Clarissa Maria de Cerqueira Mathias, Guilherme Harada, Aknar Calabrich, Alberto Julius Wainstein, Andréia Cristina de Melo, Antonio Carlos Buzaid, Artur Katz, Carlos Gil Ferreira, Carlos Henrique dos Anjos, Clarissa Baldotto, Elimar Elias Gomes, Fernando Moura, Gilberto de Castro, Guilherme Nader Marta, Gustavo dos Santos Fernandes, Luiza Dib Batista Bugiato Faria, Mariana Laloni, Paulo Marcelo Gehm Hoff, Romualdo Barroso-Sousa, Sergio Jobim de Azevedo, Vladmir Cláudio Cordeiro de Lima, William Nassib William
Publikováno v:
Brazilian Journal of Oncology, Vol 18, Iss 00 (2022)
Immunotherapy (IT) in the form of monoclonal antibodies targeting coreceptors involved in the modulation of the immune synapse represents a standard of care for patients with distinct malignancies. Over the past years, evidences supporting the clinic
Externí odkaz:
https://doaj.org/article/d7a25db8b1ed454ebec29e265ba0d6dd
Autor:
Mauricio Fernando Silva Almeida Ribeiro, Camila Bragança Xavier, Allan Andresson Lima Pereira, Mariana Scaranti, Luiza Dib Batista Bugiato Faria, Tatiana Strava Correa, Marina Sahade, David Queiroz Borges Muniz, Olavo Feher, Gustavo dos Santos Fernandes, Artur Katz, Rodrigo Ramella Munhoz
Publikováno v:
Brazilian Journal of Oncology, Vol 18, Iss 00 (2022)
Objectives: Immune-checkpoint inhibitors (ICI) and targeted-therapies (TT) have become standard options for BRAF-V600 metastatic melanomas (MM). Recently, randomized trials (RCT) addressed the efficacy of combined approaches, with conflicting results
Externí odkaz:
https://doaj.org/article/d8baab6b1db4491c84f2d3e64dbf6379
Autor:
Ana Carolina Rathsam Leite, Daniele Assad Suzuki, Allan Anderson Lima Pereira, Natalia Polidorio Machado, Romualdo Barroso-Sousa, Tatiana Strava Correa, Fernanda Cesar Moura, Igor Alexandre Protzner Morbeck, Brenda Pires Gumz, Luiza Dib Batista Bugiato Faria, Gustavo dos Santos Fernandes, Renata Lazari Sandoval
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundIdentifying individuals at a higher risk of developing cancer is a major concern for healthcare providers. Cancer predisposition syndromes are the underlying cause of cancer aggregation and young-onset tumors in many families. Germline gene
Externí odkaz:
https://doaj.org/article/c5d6f477aa174347acc50a372bfb16d2
Autor:
Gustavo dos Santos Fernandes, Daniel da Motta Girardi, Luiza Dib Batista Bugiato Faria, João Paulo Giacomini Bernardes, Renata de Almeida Coudry
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 5, Iss 1, Pp 1-4 (2017)
Abstract Background Metastatic gastric cancer (GC) is an incurable and aggressive disease with a poor prognosis. Immunotherapy is an attractive approach for treating patients with cancer, and studies using immunotherapy have shown promising results i
Externí odkaz:
https://doaj.org/article/c9d300c669d94ede96dbd0bf5d7dd7e4
Autor:
Luiza Dib Batista Bugiato Faria, Carlos Henrique dos Anjos, Gustavo dos Santos Fernandes, Igor Fernando da Silva Carvalho
Publikováno v:
Einstein (São Paulo), Vol 14, Iss 3, Pp 420-422
ABSTRACT A 69-year-old male patient, smoker, was diagnosed with small cell lung cancer metastatic to lung, liver and central nervous system. He received chemotherapy with carboplatin AUC 5 on day 1 and etoposide 100mg/m2 on days 1, 2 and 3. During th
Externí odkaz:
https://doaj.org/article/0aa7f2b758574ddcbfb65f93118dceaa
Autor:
Luiza Dib Batista Bugiato Faria, Gustavo Dos Santos Fernandes, Marcela Crosara Teixeira, Daniel Girardi, Paulo M. Hoff, Frederico Costa
Publikováno v:
Journal of Gastrointestinal Cancer. 50:860-866
Advanced pancreatic adenocarcinoma (PA) is an aggressive disease that has poor prognosis and frequently interferes with patient’s quality of life. There has been progress in first-line regimens; however, there is no standard second-line regimen. Th
Autor:
Luiza Dib Batista Bugiato Faria, João Paulo Giacomini Bernardes, Gustavo Dos Santos Fernandes, Renata A. Coudry, Daniel Girardi
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 5, Iss 1, Pp 1-4 (2017)
Journal for Immunotherapy of Cancer
Journal for Immunotherapy of Cancer
Background Metastatic gastric cancer (GC) is an incurable and aggressive disease with a poor prognosis. Immunotherapy is an attractive approach for treating patients with cancer, and studies using immunotherapy have shown promising results in melanom
Autor:
Daniel Moore Freitas Palhares, Gustavo Dos Santos Fernandes, Brenda Gumz, Luiza Dib Batista Bugiato Faria, Allan Andresson Lima Pereira, Rafael Gadia, Renata Reis Figueiredo, Katia Regina Marchetti, Marcela Alves Teixeira
Publikováno v:
Journal of Clinical Oncology. 38:154-154
154 Background: Metastatic colorectal cancer is common disease that is treated mainly with systemic chemotherapy with or without target therapy combined with local therapies when feasible. Patients with OM-CRC may benefit from local treatments, class
Autor:
Brenda Gumz, Gustavo Dos Santos Fernandes, Allan Andresson Lima Pereira, Katia Regina Marchetti, Luiza Dib Batista Bugiato Faria, Daniel Moore Freitas Palhares, Marcela Alves Teixeira, Renata Reis Figueiredo, Rafael Gadia
Publikováno v:
Journal of Clinical Oncology. 38:825-825
825 Background: Metastatic GI cancers are mainly treated with systemic treatment (ST), in selected patients (pts), surgery is considered depending on pts characteristics and institutional preferences. Stereotactic Radiotherapy (SRT) is a growing trea
Autor:
Luiza Dib Batista Bugiato Faria, Igor Fernando da Silva Carvalho, Carlos Henrique dos Anjos, Gustavo Dos Santos Fernandes
Publikováno v:
Einstein
Einstein (São Paulo), Vol 14, Iss 3, Pp 420-422
Einstein (São Paulo), Vol 14, Iss 3, Pp 420-422
A 69-year-old male patient, smoker, was diagnosed with small cell lung cancer metastatic to lung, liver and central nervous system. He received chemotherapy with carboplatin AUC 5 on day 1 and etoposide 100mg/m2 on days 1, 2 and 3. During the first c